Conference on FDA-Regulated Products and Pregnant Women; Notice of Public Meeting

Краткое содержание

The Food and Drug Administration (FDA) is announcing that the Office of Women's Health, FDA, in cooperation with the Office on Women's Health, Public Health Service; the National Institute of Child Health and Human Development, and the Office of Research on Women's Health, National Institutes of Health; and the Centers for Disease Control and Prevention, is sponsoring a public meeting to gather consumers and representatives from academia, industry, and government to discuss the scientific, legal, and ethical issues associated with testing FDA-regulated products in pregnant women.